CLINICAL TRIALS PROFILE FOR BICALUTAMIDE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for bicalutamide
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Formulation | NCT01416870 ↗ | Bioequivalence of Bicalutamide New Formulation in Japan | Terminated | AstraZeneca | Phase 1 | 2010-07-01 | The purpose of this study is to investigate the bioequivalence of Bicalutamide new formation with Casodex commercial tablet (80mg) in Japanese healthy male subjects |
| New Formulation | NCT01416883 ↗ | Oral Mucosal Absorption Study of Bicalutamide New Formulation | Terminated | AstraZeneca | Phase 1 | 2010-07-01 | The purpose of this study is to investigate the presence or absence of oral mucosal absorption of bicalutamide after ICI176,334.1 is given to Japanese healthy male subjects |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for bicalutamide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002633 ↗ | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | Completed | Eastern Cooperative Oncology Group | Phase 3 | 1995-02-08 | RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether hormone therapy plus surgery is more effective than hormone therapy plus radiation therapy for prostate cancer. PURPOSE: This randomized phase III trial is studying giving hormone therapy alone to see how well it works compared to giving hormone therapy together with bilateral orchiectomy or radiation therapy in treating patients with stage III or stage IV prostate cancer. |
| NCT00002633 ↗ | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | Completed | Medical Research Council | Phase 3 | 1995-02-08 | RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether hormone therapy plus surgery is more effective than hormone therapy plus radiation therapy for prostate cancer. PURPOSE: This randomized phase III trial is studying giving hormone therapy alone to see how well it works compared to giving hormone therapy together with bilateral orchiectomy or radiation therapy in treating patients with stage III or stage IV prostate cancer. |
| NCT00002633 ↗ | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 1995-02-08 | RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether hormone therapy plus surgery is more effective than hormone therapy plus radiation therapy for prostate cancer. PURPOSE: This randomized phase III trial is studying giving hormone therapy alone to see how well it works compared to giving hormone therapy together with bilateral orchiectomy or radiation therapy in treating patients with stage III or stage IV prostate cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for bicalutamide
Condition Name
Clinical Trial Locations for bicalutamide
Trials by Country
Clinical Trial Progress for bicalutamide
Clinical Trial Phase
Clinical Trial Sponsors for bicalutamide
Sponsor Name
